Prostate Cancer
Prostate cancer is the third most common tumor in men in Hong Kong, with over 2,500 new cases diagnosed each year. Risk factors include advancing age (>50 years) and genetics. Prostate cancer can be categorized into early-stage and advanced-stage. In the early stages, prostate cancer may not exhibit noticeable symptoms, and patients may experience similar symptoms to benign prostatic hyperplasia, such as urgency, frequency, slow urine flow, or nocturia. In advanced stages, patients may experience fatigue, bone pain, weight loss, or even hematuria, and it is crucial to seek medical attention promptly.
Doctors will conduct a digital rectal examination to assess the prostate gland, perform a blood test to measure Prostate Specific Antigen (PSA) levels, and utilize magnetic resonance imaging (MRI) scans to evaluate the locations and staging of prostate tumors. Prostate biopsy may be required to confirm the malignancy and provide moreinformation on the staging of prostate cancer.
Based on the patient’s age, physical condition, and stage of prostate cancer, urologist will formulate an appropriate treatment plan. Early-stage prostate cancer patients may undergo surgery or radiation therapy for curative purposes. Late-stage prostate cancer patients may receive hormone therapy in combination with novel oral hormone medications or chemotherapy to effectively control the disease.
Minimally invasive surgical options are available for early to mid-stage prostate cancer, where urologists utilize robotic assistance for more precise prostatectomy. Compared to traditional surgery, this approach significantly improves outcomes in terms of bleeding, pain, and recovery.
Men often prioritize work and tend to overlook their health. Men over 50 years old should undergo regular prostate health check-ups. Those with a family history of prostate cancer or high-risk factors such as smoking should pay attention to any changes during urination and seek medical attention promptly if any abnormalities are noticed.
(Staging of prostate cancer)
(Robotic surgical system)
